
    
      The purpose of the study is to evaluate the clinical efficacy and general tolerability of two
      different subcutaneous hMG preparations (hMG-IBSA, IBSA vs Menopur, Ferring Pharmaceuticals,
      Inc.) when administered to patients undergoing controlled ovarian stimulation for IVF.
    
  